The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2022 | Leukemic cell birth rate & the role of recently divided B cells in CLL
Nicholas Chiorazzi, MD, Feinstein Institute for Medical Research, Manhasset, NY, discusses the association between leukemic cell birth rate and patient outcomes in chronic lymphocytic leukemia (CLL), commenting on the impact of recently divided B cells on disease evolution. Prof. Chiorazzi explains that these recently divided B cells are able to communicate with T cells to induce B cell survival and prevent the generation of cytolytic T cells. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
